Margolese Howard C, Malchy Leslie, Negrete Juan Carlos, Tempier Raymond, Gill Kathryn
Addictions Unit, McGill University Health Centre, Montreal, Quebec, Canada.
Schizophr Res. 2004 Apr 1;67(2-3):157-66. doi: 10.1016/S0920-9964(02)00523-6.
Patients with schizophrenia and related psychoses frequently use, abuse and become dependent on psychoactive substances. Local surveys indicate differences in both types and patterns of substances used. A cross-sectional survey was conducted to document abuse in 207 successive outpatients presenting to a psychiatric continuing care facility in a large Canadian city. Nicotine, alcohol and cannabis were the most frequently abused substances in the cohort. Excluding nicotine, 44.9% met criteria for lifetime and 14.0% for current abuse/dependence. Cocaine, heroin, hallucinogen, amphetamine, and inhalant use were rarely reported. Patients with current substance abuse/dependence and a psychotic disorder (dual diagnosis, DD) had significantly higher Positive and Negative Symptom Scale (PANSS) positive scores than lifetime-DD or those with a single diagnosis (SD). Significantly more current-DD (69.0%) patients were depressed (HAM-D score > or =12) compared to SD (45.6%). Furthermore, current-DD (27.6%) patients were more likely than SD (4.5%) to be medication non-compliant. Patients with current-DD were more likely to smoke cigarettes (88.9%) compared to those with SD (49.6%) and they had significantly longer histories of cigarette smoking (19.1 for DD vs. 11.5 years for SD). The smoking behavior of the DD population is discussed in terms of enhanced risk for alcohol abuse, as well as effects on antipsychotic blood levels and metabolism.
精神分裂症及相关精神病患者经常使用、滥用并依赖精神活性物质。当地调查表明,所使用物质的类型和模式存在差异。我们进行了一项横断面调查,以记录在加拿大一个大城市的一家精神病持续护理机构就诊的207名连续门诊患者中的物质滥用情况。尼古丁、酒精和大麻是该队列中最常被滥用的物质。排除尼古丁后,44.9%的患者符合终生滥用标准,14.0%的患者符合当前滥用/依赖标准。很少有患者报告使用可卡因、海洛因、致幻剂、安非他明和吸入剂。当前存在物质滥用/依赖且患有精神障碍(双重诊断,DD)的患者的阳性和阴性症状量表(PANSS)阳性得分显著高于终生双重诊断患者或单一诊断(SD)患者。与单一诊断患者(45.6%)相比,当前双重诊断患者(69.0%)中抑郁(汉密尔顿抑郁量表评分≥12)的比例显著更高。此外,当前双重诊断患者(27.6%)比单一诊断患者(4.5%)更有可能不遵医嘱服药。与单一诊断患者(49.6%)相比,当前双重诊断患者吸烟的可能性更大(88.9%),且他们的吸烟史显著更长(双重诊断患者为19.1年,单一诊断患者为11.5年)。本文从酒精滥用风险增加以及对抗精神病药物血药浓度和代谢的影响方面讨论了双重诊断人群的吸烟行为。